Tyrosine aminotransferase (EC 2.6.1.5; TAT) is an example of a cytosolic hepatic enzyme with a short half-life, 1.5-2 h (Groenewald et al., 1984) . Synthesis of TAT is regulated by several hormones but little is known of either the pathway or control of degradation. From measurements of changes in enzyme activity, it has been suggested that components of cellular membranes initiate TAT degradation by a process which may involve disulphide exchange (Beneking et al., 1978; Di Cola & Federici, 1982) . In intact cells, insulin and cyclic G M P have been implicated in the control of inactivation, and hence degradation, of TAT (Spencer et at., 1978; Strinden & Stellwagen, 1981 , 1982 . We have used immunoprecipitation to monitor the effects of insulin and cyclic G M P on the loss of TAT in primary cultures of isolated rat hepatocytes.
Hepatocytes were isolated from fed rats (Elliott at al., 1976) and cultured on collagen-coated plates (Carpenter et al., 1983) . The medium contained dexamethasone (10 -' M ) and, for prelabelling of cell proteins in the measurement of degradation of total proteins and TAT, ~-[4,5-'H]leucine (specific activity, 9.134 pCi/pmol). After 19 h, all cells were incubated for a further 4 h in the absence of exogenous radioisotope with or without dexamethasone (lo-' M). Throughout this period ('pulse-chase') cultures were analysed for (i) changes in TAT activity (Marston & Pogson, 1977) , (ii) degradation of total proteins, i.e. production of radioactive products soluble in 5% trichloroacetic acid (TCA), and (iii) loss of immunoreactive radioisotopically labelled TAT (Stanley et al., 1984) .
Total protein degradation was constant throughout the 'pulse-chase' phase and was unaltered by dexamethasone. The average rate of degradation, 2.26 f 0.18%/h (mean ~s . E . M . for 10 experiments), is comparable with that for total liver proteins in vivo (Garlick et al., 1975) . Loss of TAT immunoreactivity occurred at a constant rate of 10.65 f O.68%/h (mean f S.E.M. for 10 experiments). Dexamethasone did not influence TAT loss. The measured half7 life (4.7 h) is greater than that determined by other methods and may indicate either that TAT degradation proceeds through an intermediate immunoreactive form of the enzyme which fails to display activity or that the conditions of cell culture may prolong TAT stability. Total TAT activity was not altered during the 'pulse-chase' phase although small decreases in activity were noticed in the final hour of incubation in the absence of dexamethasone. This indicates a dynamic balance between degradation and synthesis of TAT.
Total protein degradation was inhibited by insulin (Table I) . Insulin inhibited loss of TAT immunoreactivity but the effect was only significant in the presence of dexamethasone. Thus corticosteroids may be required to maintain synthesis of a rapidly turning over protein which is essential for expression of the effects of insulin on TAT loss.
Vanadate mimics several biological effects of insulin (Seglen & Gordon, 1981) . Although vanadate inhibited total protein degradation, in agreement with previous reports (Seglen, 1983) , no significant effect on loss of TAT immunoreactivity was observed (Table I) . Thus the action of insulin upon TAT loss occurs through mechanisms which cannot be modified by vanadate. Inverse correlations have been measured between cyclic G M P content of hepatocytes and loss of TAT activity; indeed it has been suggested that insulin effects on TAT activity might be produced by modulation of cyclic G M P content (Strinden & Stellwagen, 1981 , 1982 . Neither nitroprusside, which stimulates guanylate cyclase (Ignarro et al., 1980) , nor the 8-bromo analogue of cyclic G M P were able to influence loss of TAT immunorectivity or total protein degradation (Table I) .
Loss of TAT immunoreactivity represents an early step in the pathway of degradation of the enzyme. Insulin inhibits this process by a mechanism inaccessible to stimulation by vanadate and independent of changes in cyclic G M P content.
We thank the Wellcome Trust for financial support. Under normal physiological conditions the major site of glutamine catabolism in the rat is the small intestine, where glutamine is used as a respiratory fuel for enterocytes (Windmueller, 1984) . Lactation is accompanied by hypertrophy of the small intestine (Table 1; Cairnie & Bentley, 1967) . In addition, the mammary gland removes large amounts of glutamine from the circulation (Vina et al., 198 I). Thus, during lactation the potential for glutamine degradation is increased.
Long-term streptozotocin diabetes is another condition accompanied by hypertrophy of the small intestine. We have shown (Watford et al., 1984; Erbelding, 1985) that despite a large increase in intestinal glutaminase activity in such rats, glutamine metabolism by this organ decreases and alternative respiratory fuels are used. A major factor responsible for decreased glutamine metabolism by the small intestine in these animals was a marked decrease in arterial glutamine levels, resulting in substrate unavailability (Watford et al., 1984; Erbelding, 1985) .
We have studied the regulation of glutamine metabolism in lactating (day 16) rats. During lactation, arterial glutamine concentrations are maintained at levels seen in control rats ( Table 1) . The small intestine increased in size. This was accompanied by increased activity of phosphate-activated glutaminase in this organ when expressed relative to body Table I . Glutamine metaboIism in the lactating rut Female Sprague-Dawley rats were allowed free access to food and water at all times. Ateriovenous difference measurements for liver, hindquarters and portal drained viscera were as previously reported by Lund & Watford (1976) and Watford et al. (1984) and by Vina et al. (1981) for mammary gland. Glutamine synthetase activity was determined using the method of Wellner & Meister (1966) . All other procedures were as described previously (Watford et al., 1984) . Results are expressed as means S.E.M. of the number of observations given in parentheses. N.D., Not determined. 
